RecruitingNot Applicable

GDF-15 and Early Outcomes After LVAD Implantation

Turkey (Türkiye)48 participantsStarted 2026-02-04

Plain-language summary

This observational study aims to investigate the association between preoperative GDF-15 levels and early postoperative outcomes in patients undergoing left ventricular assist device (LVAD) implantation. The study will evaluate whether elevated preoperative GDF-15 levels are associated with adverse early outcomes, including postoperative complications and mortality. The findings may help improve preoperative risk assessment and identify high-risk patients before LVAD implantation.

Who can participate

Age range18 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria:Adults aged 18 years and older Patients with advanced heart failure undergoing LVAD implantation Availability of preoperative GDF-15 measurement Ability to provide written informed consent or consent provided by a legally authorized representative, according to local regulations - Exclusion Criteria:Age under 18 years Active infection Active malignancy Severe hepatic failure Missing study data Refusal to participate \-

What they're measuring

Early Postoperative Mortality

Timeframe: 30 days after LVAD implantation

Trial details

NCT IDNCT07497308

SponsorAkdeniz University

Sponsor typeOTHER

Study typeOBSERVATIONAL

Primary completion2026-08-10

Contact for this trial

emel gündüz, md

+902422496000 dregunduz@hotmail.com

View on ClinicalTrials.gov More Advanced Heart Failure trials